Table 3

Pharmacokinetic parameters derived from blood counting data in 111In-labeled 2A11 nuclear medicine study.

1 mg/m210 mg/m2100 mg/m2250 mg/m2
Total AUC (%) ID × h/ml)2.25 ± 0.222.43 ± 1.03.10 ± 0.522.33 ± 0.31
T1/2 α (h)0.71 ± 0.73.22 ± 7.42.99 ± 0.751.19 ± 0.75
T1/2 β (h)51.82 ± 10.9464.23 ± 2.360.19 ± 7.0163.66 ± 4.97